Drug intelligence / Profile preview

AMG9810

Development stage
Discontinued
Lead developer
Amgen
Modality
Small Molecules
Administration
Topical, Oral, Intraplantar Injection
01

Overview

AMG9810 is a potent and selective small molecule antagonist of the **transient receptor potential vanilloid 1 (TRPV1)** receptor, also known as the vanilloid receptor 1. Developed by **Amgen**, it acts as a competitive inhibitor that blocks TRPV1 activation by various stimuli, including capsaicin, heat, protons, and endogenous ligands. While it has been extensively used as a pharmacological research tool to investigate the role of TRPV1 in **inflammatory and neuropathic pain**, it has not transitioned into clinical development for medical use. In preclinical studies, AMG9810 demonstrated significant antihyperalgesic and analgesic properties, effectively blocking all known modes of TRPV1 activation.

Other names
(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)acrylamide
02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)

Beyond the preview

Go deeper on AMG9810.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMG9810.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call